BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32150007)

  • 1. Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir.
    Copelyn J; Hincks JR; Wilmshurst JM; Petersen W; Howard W; Jallow S; Moonsamy S; Seakamela L; Suchard M; Collett MS; Eley B
    Pediatr Infect Dis J; 2020 May; 39(5):435-437. PubMed ID: 32150007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.
    Collett MS; Hincks JR; Benschop K; Duizer E; van der Avoort H; Rhoden E; Liu H; Oberste MS; McKinlay MA; Hartford M
    J Infect Dis; 2017 Feb; 215(3):335-343. PubMed ID: 27932608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis.
    Torres-Torres S; Myers AL; Klatte JM; Rhoden EE; Oberste MS; Collett MS; McCulloh RJ
    Pediatr Infect Dis J; 2015 Jan; 34(1):52-4. PubMed ID: 25229269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.
    Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R
    Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.
    Bearden D; Collett M; Quan PL; Costa-Carvalho BT; Sullivan KE
    J Allergy Clin Immunol Pract; 2016; 4(6):1059-1065. PubMed ID: 26883540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies.
    Minor P
    Dev Biol (Basel); 2001; 105():75-80. PubMed ID: 11763340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
    McKinlay MA; Collett MS; Hincks JR; Oberste MS; Pallansch MA; Okayasu H; Sutter RW; Modlin JF; Dowdle WR
    J Infect Dis; 2014 Nov; 210 Suppl 1():S447-53. PubMed ID: 25316866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters.
    Kalkowska DA; Pallansch MA; Thompson KM
    Epidemiol Infect; 2019 Oct; 147():e295. PubMed ID: 31647050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure.
    Jallow S; Wilmshurst JM; Howard W; Copelyn J; Seakamela L; Chan KW; Sebunya R; Sibiya R; Du Plessis H; Jacobs C; Berkowitz N; Blumberg L; McCarthy K; Maseti E; Kamupira M; Dlamini N; Gumede N; Diop OM; Lau YL; Moonsamy S; Eley B; Suchard M
    Clin Infect Dis; 2020 Jan; 70(1):132-135. PubMed ID: 31086993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect infection by oral polio vaccine virus following natural exposure among inactivated polio vaccine recipients.
    Gary HE; Smith B; Jenks J; Ruiz J; Sessions W; Vinje J; Sobsey M
    Epidemiol Infect; 2008 Feb; 136(2):180-3. PubMed ID: 17376256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia.
    Fiore L; Plebani A; Buttinelli G; Fiore S; Donati V; Marturano J; Soresina A; Martire B; Azzari C; Nigro G; Cardinale F; Trizzino A; Pignata C; Alvisi P; Anastasio E; Bossi G; Ugazio AG
    Clin Immunol; 2004 Apr; 111(1):98-102. PubMed ID: 15093557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.
    Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A
    Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Analysis of Antiviral Compounds Against Poliovirus.
    Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J
    Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.
    Hennessey KA; Lago H; Diomande F; Akoua-Koffi C; Caceres VM; Pallansch MA; Kew OM; Nolan M; Zuber PL
    J Infect Dis; 2005 Dec; 192(12):2124-8. PubMed ID: 16288377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.